Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Consumer Goods Press Releases .
Press releases published on July 25, 2025

Investors in XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP Should Contact Levi & Korsinsky Before September 8, 2025 to Discuss Your Rights – XIFR
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Investors who lost money on Capricor Therapeutics, Inc. (CAPR) should contact Levi & Korsinsky about pending Class Action - CAPR
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Hims & Hers Health, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights – HIMS
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Reddit, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 18, 2025 to Discuss Your Rights – RDDT
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Investors in Vestis Corporation Should Contact Levi & Korsinsky Before August 8, 2025 to Discuss Your Rights – VSTS
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Contact Levi & Korsinsky by September 5, 2025 Deadline to Join Class Action Against iRobot Corporation (IRBT)
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Shareholders that lost money on Biohaven Ltd.(BHVN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 8, 2025 in PepGen Inc. Lawsuit – PEPG
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

3D Systems Corporation Class Action: Levi & Korsinsky Reminds 3D Systems Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 12, 2025 – DDD
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Notifies Shareholders of Petco Health and Wellness Company, Inc.(WOOF) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Reckitt Benckiser Group plc Class Action: Levi & Korsinsky Reminds Reckitt Benckiser Group plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 4, 2025 – RBGLY
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Shareholders that lost money on Alto Neuroscience, Inc.(ANRO) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Fortrea Holdings Inc. Class Action: Levi & Korsinsky Reminds Fortrea Holdings Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 1, 2025 – FTRE
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Shareholders that lost money on Sarepta Therapeutics, Inc.(SRPT) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi …

Nutex Health Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 25, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) investors that the firm has …

Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer
MINNEAPOLIS, July 25, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the Company will hold a conference call and webcast on Monday, July …

Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
Initial results demonstrate numerical improvement of cognitive and functional measures with inidascamine across both active treatment arms compared to placebo, but did not meet statistical significance on the primary endpoint Inidascamine continues to …

Business Reporter: It’s time to rethink customer surveys
How an immersive approach can help engage meaningfully with all generations LONDON, UNITED KINGDOM, July 25, 2025 /EINPresswire.com/ -- In an interview published on Business Reporter, Riccardo Tumminello, FFIND’s Global Marketing Director talks about …

RBGLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Reckitt Benckiser Group PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …